Lincocin (lincomycin HCl)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Lincomycin, a lincosamide antibiotic, is structurally related to clindamycin.
USES: This medication is used to treat a wide variety of bacterial infections. It works by stopping the growth of bacteria.
Generic name: lincomycin HCl
Pronunciation: (LIN-koe-MYE-sin)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Lincocin
Indications
The following indications are listed for Lincocin:
- Pneumococcal Infection
- Staphylococcus Infections
- Streptococcal Infection
Also known as: Diplococcus Pneumoniae Infection, Fraenkel's Pneumococcus Infection, Fraenkel-Weichselbaum Pneumococcus Infection, Pneumococcus Infection, Pneumonococcus Infection, Staphylococcal Infectious Disease, Staphylococcus Species Infection, Staphylococcus Spp. Infection, Streptococcal Infectious Disease, Streptococcus Pneumoniae Infectious Disease.
Dosing
Dosage of lincomycin hydrochloride is expressed in terms of lincomycin and depends on the severity of the infection.
Lincomycin hydrochloride is administered by IM injection or slow IV infusion. The drug should not be given by rapid IV injection.
Lincomycin hydrochloride has been administered by subconjunctival injection. Although lincomycin has been administered orally, an oral preparation is not commercially available in the US.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
Animal reproduction studies have not been performed with lincomycin to evaluate the teratogenic potential of the drug, and there are no adequate and well-controlled studies using the drug in pregnant women. Lincomycin should be used during pregnancy only when clearly needed.
Reproduction studies in rats using oral lincomycin dosages up to 1000 mg/kg (1.2 times the maximum daily human dosage based on mg/m2) have not revealed adverse effects on survival of offspring from birth to weaning.
Lincomycin hydrochloride injection contains benzyl alcohol as a preservative; benzyl alcohol can cross the placenta. (See Cautions: Pediatric Precautions.)
Lincomycin is distributed into milk. Because of the potential for serious adverse reactions from lincomycin in nursing infants, a decision should be made whether to discontinue nursing or the drug, taking into account the importance of the drug to the woman.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.